Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis

Brittany N. Palasik, Hongmei Wang

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds